CINP World Congress of Neuropsychopharmacology

May 7-10, 2023
Montreal, Canada

Clinical PosterS

The scientific posters accessible via this website have been developed and financially supported by Sumitomo Pharma America, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc.

Copies of posters obtained through this site are for personal use only and may not be reproduced without written permission from the authors.

EVIDENCE FOR THE THERAPEUTIC POTENTIAL OF TAAR1 AGONIST ULOTARONT IN SCHIZOPHRENIA: REVIEW OF PRECLINICAL AND CLINICAL STUDIES

Kenneth S. Koblan, Seth C. Hopkins, Nina Dedic, Courtney Zeni, Heather Dworak


Download the PDF: CLICK HERE 

View interactive iPoster: CLICK HERE